The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS

Mark de SerresPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USACorrespondence[email protected]

Lee MossPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

James SigafoosPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

Andrea SeflerPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

Stephen CastellinoPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

Gary BowersPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

Cosette Serabjit-SinghPreclinical Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, USA

Your download is now in progress and you may close this window